American Century Companies’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
Other funds holding APLS
ACA
EC
OCA
American Century Companies's APLS Position: Q3 2023 in Review
American Century Companies sold out of Apellis Pharmaceuticals (APLS) in Q3 2023, closing a stake of 4,626 shares — an estimated $421K sold.
American Century Companies first reported a position in APLS in Q1 2022 and held it in 6 quarters. The position peaked at $15.2M in Q1 2023. 256 funds tracked by Wall St. Rank hold APLS as of Q3 2023.
- American Century Companies reported no remaining Apellis Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
- American Century Companies sold 4,626 Apellis Pharmaceuticals shares in Q3 2023, an estimated $421K.
- American Century Companies first reported a position in Apellis Pharmaceuticals in Q1 2022 and held it in 6 quarters.
- American Century Companies's Apellis Pharmaceuticals position peaked at $15.2M in Q1 2023.
- 256 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q3 2023.
Based on American Century Companies's 13F filing for Q3 2023, filed 13 Nov 2023.